US Food and Drug Administration and design of drug approval studies

JAMA. 2014 Nov 26;312(20):2163-5. doi: 10.1001/jama.2014.13329.

Authors

Steven Woloshin¹, Lisa M Schwartz¹, Brittney Frankel², Adrienne Faerber¹

Affiliations

¹ Center for Medicine and the Media, The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, New Hampshire.
² Cornell-Weill Medical School, New York, New York.

PMID: 25423223
DOI: 10.1001/jama.2014.13329

No abstract available

MeSH terms

Clinical Protocols
Clinical Trials as Topic
Communication
Drug Approval / methods*
Drug Industry*
Research Design
United States
United States Food and Drug Administration*